Melafind, New Melanoma-Diagnosing Tool, Receives FDA Approval
Huge news in skin cancer treatment: Melafind, a device to help diagnose early melanoma, was recently approved by the FDA and will be on the market soon. Up until now, the best technique to diagnose melanoma, short of surgical biopsy, has been the clinical examination. Melafind gives dermatologists objective information about questionable lesions in order to […]
- Posted on: Nov 10 2011